Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Cells ; 13(14)2024 Jul 15.
Article in English | MEDLINE | ID: mdl-39056778

ABSTRACT

Colorectal cancer (CRC) is the third most prevalent cancer worldwide. Current studies have demonstrated that tumor-derived extracellular vesicles (EVs) from different cancer cell types modulate the fibroblast microenvironment to contribute to cancer development and progression. Here, we isolated and characterized circulating large EVs (LEVs), small EVs (SEVs) and non-EV entities released in the plasma from wild-type (WT) mice and the APCMin/+ CRC mice model. Our results showed that human colon fibroblasts exposed from APC-EVs, but not from WT-EVs, exhibited the phenotypes of cancer-associated fibroblasts (CAFs) through EV-mediated NF-κB pathway activation. Cytokine array analysis on secreted proteins revealed elevated levels of inflammatory cytokine implicated in cancer growth and metastasis. Finally, non-activated cells co-cultured with supernatant from fibroblasts treated with APC-EVs showed increased mRNA expressions of CAFs markers, the ECM, inflammatory cytokines, as well as the expression of genes controlled by NF-κB. Altogether, our work suggests that EVs and non-EV components from APCMin/+ mice are endowed with pro-tumorigenic activities and promoted inflammation and a CAF-like state by triggering NF-κB signaling in fibroblasts to support CRC growth and progression. These findings provide insight into the interaction between plasma-derived EVs and human cells and can be used to design new CRC diagnosis and prognosis tools.


Subject(s)
Extracellular Vesicles , Fibroblasts , NF-kappa B , Signal Transduction , Animals , Extracellular Vesicles/metabolism , NF-kappa B/metabolism , Humans , Mice , Fibroblasts/metabolism , Colon/pathology , Colon/metabolism , Adenomatous Polyposis Coli Protein/metabolism , Adenomatous Polyposis Coli Protein/genetics , Carcinogenesis/pathology , Carcinogenesis/genetics , Carcinogenesis/metabolism , Mice, Inbred C57BL , Colorectal Neoplasms/pathology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/genetics , Tumor Microenvironment , Cytokines/metabolism , Cancer-Associated Fibroblasts/metabolism , Cancer-Associated Fibroblasts/pathology
2.
Int J Mol Sci ; 22(19)2021 Sep 23.
Article in English | MEDLINE | ID: mdl-34638604

ABSTRACT

The nano-sized membrane enclosed extracellular vesicles (EVs) released by virtually all cell types play an essential role in intercellular communication via delivering bio-molecules, such as nucleic acids, proteins, lipids, and other molecules to recipient cells. By mediating an active and steady-state cell-to-cell communication, EVs contribute to regulating and preserving cellular homeostasis. On the other hand, EVs can also spread pathogen-derived molecules during infections, subverting the host immune responses during infections and thus worsening pathophysiological processes. In recent years, the biological functioning of EVs has become a widespread research field in basic and clinical branches of medical sciences due to their potential role in therapeutic applications for several diseases. This review aims to summarize the main recent findings regarding the implication of EVs shed by human macrophages (MΦ-EVs) and how they can modulate the host immune response to control or increase the damage caused by infectious agents. We will also present the methods used to describe MΦ-EVs, as well as the potential of these EVs as disease diagnostic tools for some human pathogens. We believe that an in-depth understanding of the host-pathogen interactions mediated by MΦ-EVs may trigger the development of innovative therapeutic strategies against infectious diseases.


Subject(s)
Extracellular Vesicles/physiology , Host-Pathogen Interactions/physiology , Macrophages/physiology , Cell Communication/physiology , Communicable Diseases/pathology , Communicable Diseases/physiopathology , Humans
3.
PLoS One ; 15(8): e0237795, 2020.
Article in English | MEDLINE | ID: mdl-32833989

ABSTRACT

Extracellular vesicles (EVs) are small membrane-limited structures derived from outward budding of the plasma membrane or endosomal system that participate in cellular communication processes through the transport of bioactive molecules to recipient cells. To date, there are no published methodological works showing step-by-step the isolation, characterization and internalization of small EVs secreted by human primary macrophages derived from circulating monocytes (MDM-derived sEVs). Thus, here we aimed to provide an alternative protocol based on differential ultracentrifugation (dUC) to describe small EVs (sEVs) from these cells. Monocyte-derived macrophages were cultured in EV-free medium during 24, 48 or 72 h and, then, EVs were isolated from culture supernatants by (dUC). Macrophages secreted a large amount of sEVs in the first 24 h, with size ranging from 40-150 nm, peaking at 105 nm, as evaluated by nanoparticle tracking analysis and scanning electron microscopy. The markers Alix, CD63 and CD81 were detected by immunoblotting in EV samples, and the co-localization of CD63 and CD81 after sucrose density gradient ultracentrifugation (S-DGUC) indicated the presence of sEVs from late endosomal origin. Confocal fluorescence revealed that the sEVs were internalized by primary macrophages after three hours of co-culture. The methodology here applied aims to contribute for enhancing reproducibility between the limited number of available protocols for the isolation and characterization of MDM-derived sEVs, thus providing basic knowledge in the area of EV methods that can be useful for those investigators working with sEVs released by human primary macrophages derived from circulating monocytes.


Subject(s)
Cell Communication , Extracellular Vesicles/metabolism , Macrophages/metabolism , Blood Buffy Coat/cytology , Cell Differentiation , Cell Fractionation/methods , Centrifugation, Density Gradient/methods , Coculture Techniques , Healthy Volunteers , Humans , Intravital Microscopy , Macrophages/cytology , Macrophages/ultrastructure , Microscopy, Confocal , Microscopy, Electron, Scanning , Microscopy, Fluorescence , Monocytes/physiology , Primary Cell Culture
4.
Environ Sci Pollut Res Int ; 27(33): 41609-41622, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32691321

ABSTRACT

In this work, the degradation of sulfamethazine (SMT), sulfadiazine (SMD), and sulfamethoxazole (SMX) by using UV light, UV/H2O2, and UV/S2O8-2 was analyzed. Direct photolysis was studied by varying the lamp power and the solution pH. DFT calculations were carried out to corroborate the efficiency of the degradation as a function of the solution pH. The variation of the apparent rate constant, kap, was determined in the indirect photolysis by employing an experimental Box-Behnken-type response surface design. The results evidenced that SMX can be efficiently degraded by applying UV radiation independent of the operating conditions. Nevertheless, the quantum yields for SMT and SMD were close to zero, indicating a low energy efficiency for their photochemical transformation. The effect of the solution pH showed that the photodegradation of sulfonamides depends both on the amount of radiation absorbed as the electronic density. Calculations based on density functional theory and supported by the quantum theory of atoms in molecules allowed to describe fragmentation patterns in the systems under study, proving the lability of S14-C2, N17-C18, and N22-O22 bonds, for SMT, SMD, and SMX, respectively. From response surface methodology, four statistically reliable equations were obtained to determine the kap value as a function of the system operating conditions. Finally, SO4•- radicals proved to have a higher reactivity to degrade SMT and SMD compared with HO• radicals regardless of the operating conditions of the system.


Subject(s)
Sulfamethoxazole , Water Pollutants, Chemical , Density Functional Theory , Hydrogen Peroxide , Kinetics , Oxidation-Reduction , Photolysis , Sulfadiazine , Sulfamethazine , Ultraviolet Rays
5.
Acta Gastroenterol Latinoam ; 46(2): 106-9, 2016 06.
Article in Spanish | MEDLINE | ID: mdl-28703565

ABSTRACT

Hemangiomas are benign vascular tumors, whose origin comes from the embryonic mesodermal tissue remains. The liver is the most common location. Its location in the teres ligament is extremely rare. This is a 59 years old male admitted because of episodes of epigastric pain for six months. A CT scan and MRI demostrated a 2 cm diameter lesion located near the Teres ligament. Laparoscopic resection was performed. Hemangiomas are the most common benign solid tumors located in the liver. They represents 73% of all benign liver tumors. MRI is the imaging of greater certainty for diagnosis. The Teres ligament (ligamentum teres hepatis) is a fibrous cord resulting in obliteration of the umbilical vein. The location of hemangiomas in this region is extremely rare but should be considered and should make the differential diagnosis with a pedicled hepatic hemangioma or gastointestinal stromal tumors.


Subject(s)
Hemangioma/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Round Ligament of Liver/diagnostic imaging , Hemangioma/surgery , Humans , Liver Neoplasms/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Round Ligament of Liver/surgery , Tomography, X-Ray Computed
6.
Acta Gastroenterol Latinoam ; 45(2): 143-54, 2015 Jun.
Article in Spanish | MEDLINE | ID: mdl-26353467

ABSTRACT

INTRODUCTION: Obesity today is a major health problem worldwide and the leading health problem in Western countries because it is associated with multiple comorbidities that increase the mortality of these patients. MATERIAL AND METHODS: A review of the literature was done in PubMed (Medline) and Cochrane Library of randomized controlled trials comparing gastric bypass with sleeve gastrectomy in the treatment of obesity and type 2 diabetes mellitus (T2DM). Eighteen papers were found, of which eleven met the initial inclusion criteria. DISCUSSION: The variables analyzed to determine the superiority of one technique over the other were: the percentage ofexcess BMI lost (% EIMCP), the percentage of excess weight loss (% EPP), BMI at the end of the study, lost Kg and the percentage of weight lost. Regarding the control of T2DM fasting glycemia, the glycosylated hemoglobin (HbAlc), whether or not oral agents or insulin were considered. CONCLUSION: No highlighting differences in results that can be obtained with RYGB and MG to control obesity and T2DM. Either method achieves excellent results, even surpassing those obtained with dietary, pharmacological and behavioral treatment.


Subject(s)
Diabetes Mellitus, Type 2/complications , Gastrectomy/methods , Gastric Bypass/methods , Obesity, Morbid/complications , Obesity, Morbid/surgery , Weight Loss , Gastrectomy/adverse effects , Gastric Bypass/adverse effects , Humans , Randomized Controlled Trials as Topic , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...